Amir Reichman
Chief Executive Officer, Director · Scinai Immunotherapeutics Ltd.
Individual
- 2026
- Jun 18, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Amir Reichman's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Frank Torti - $82.04M in ROIV purchases and sales in the last 12 months
- Eric Venker - $80.09M in ROIV purchases and sales in the last 12 months
- ILLUMINA, INC. - $79.85M in GRAL purchases and sales in the last 12 months
- Darren M. Black - $77.56M in LFST purchases and sales in the last 12 months
- Noubar Afeyan - $75.00M in GENB purchases and sales in the last 12 months
- Andrew J. Mills - $75.00M in MDLN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Amir Reichman?
Amir Reichman is a corporate insider, tracked as Chief Executive Officer, Director of Scinai Immunotherapeutics Ltd. (SCNI). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Amir Reichman last file a Form 4?
The only primary Form 4 on record is dated 18 June 2026.
